Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Psychemedics Corp. (PMD)
NASDAQ:PMD
Psychemedics (PMD) Stock Price & Analysis
99 Followers
PMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.85 - $7.25
Previous Close$5.51
Volume2.71K
Average Volume (3M)6.26K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.46M
Total Debt (Recent Filing)$3.92M
Price to Earnings (P/E)-15.3
Beta0.21
Next EarningsMar 07, 2023
EPS EstimateN/A
Last Dividend Ex-DateDec 01, 2022
Dividend Yield0.26 (3.74%)
1Y Price TargetN/A
EPS (TTM)-0.36
Shares Outstanding5,644,696
R-Squared0.08
Standard Deviation0.11
10 Day Avg. Volume3,307
30 Day Avg. Volume6,262
Price to Book (P/B)2.70
Price to Sales (P/S)1.62
Price to Cash Flow (P/CF)8.80
P/FCF Ratio15.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.02
Number of Analyst Covering0
Psychemedics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PMD FAQ
What was Psychemedics’s price range in the past 12 months?
Psychemedics lowest stock price was $4.85 and its highest was $7.25 in the past 12 months.
What is Psychemedics’s market cap?
Currently, no data Available
When is Psychemedics’s upcoming earnings report date?
Psychemedics’s upcoming earnings report date is Mar 07, 2023 which is in 31 days.
How were Psychemedics’s earnings last quarter?
Psychemedics released its earnings results on Nov 09, 2022. The company reported -$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.017.
Is Psychemedics overvalued?
According to Wall Street analysts Psychemedics’s price is currently Overvalued.
Does Psychemedics pay dividends?
Psychemedics pays a Annually dividend of $0.07 which represents an annual dividend yield of 3.74%. See more information on Psychemedics dividends here
What is Psychemedics’s EPS estimate?
Psychemedics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psychemedics have?
Psychemedics has 5,644,696 shares outstanding.
What happened to Psychemedics’s price movement after its last earnings report?
Psychemedics reported an EPS of -$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.644%.
Which hedge fund is a major shareholder of Psychemedics?
Among the largest hedge funds holding Psychemedics’s share is Royce & Associates LLC. It holds Psychemedics’s shares valued at N/A.
---
Psychemedics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 37.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $495.0 over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.37%
12-Months-Change
Fundamentals
Return on Equity
-15.67%
Trailing 12-Months
Asset Growth
-13.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Psychemedics Corp.
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
---
ATI Physical Therapy
―
Bitech Technologies Corporation
―
Medical Marijuana
―
Cryo-Cell International
―
---